ONO-4059 Study in Patients With Steroid-resistant Pemphigus
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to ONO Pharmaceutical Co., Ltd.
Related studies linked through entity extraction aliases.
Study to ONO-4538 in Patients With Rhabdoid Tumor
- Status
- RECRUITING
- Phase
- PHASE2
A Study of ONO-7018 in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL
- Status
- TERMINATED
- Phase
- PHASE1
A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced/Recurrent Gastric Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)
- Status
- COMPLETED
- Phase
- PHASE3